Home › Funds › Kera Capital Partners, Inc. › CDNA
Kera Capital Partners, Inc. position in CDNA
CAREDX INC · Health Care
Kera Capital Partners, Inc. reported holding 91,108 shares of CDNA (CAREDX INC) in its Q3 2026 13F filing — a position valued at US$6.3M, representing 0.52% of its reported portfolio and ranking #46 among its reported holdings. Kera Capital Partners, Inc. has disclosed CDNA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Kera Capital Partners, Inc.'s CDNA position evolved
Kera Capital Partners, Inc. first disclosed a stake in CDNA in Q2 2026 at 91,108 shares (US$2.6M). The position peaked in Q3 2026 at 91,108 shares, worth US$6.3M. Across 2 filings, Kera Capital Partners, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 91,108 shares valued at US$6.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 91.11K | $2.60M | New |
| Q3 2026 | 91.11K | $6.30M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 46 other funds we track also report a position in CDNA — the largest reported positions include ARK Invest (US$104.6M), GAGNON SECURITIES LLC (US$69.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- ARK Invest 1.61M sh · $104.59M · Q3 2026
- GAGNON SECURITIES LLC 1.07M sh · $69.84M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.00M sh · $56.93M · Q2 2026
- Amova Asset Management Americas, Inc. 625.42K sh · $40.63M · Q3 2026
- Ophir Asset Management Pty Ltd 1.26M sh · $36.05M · Q2 2026
- BRAIDWELL LP 1.22M sh · $34.79M · Q2 2026
- Blue Water Life Science Advisors, LP 1.19M sh · $33.91M · Q2 2026
- Zweig-DiMenna Associates LLC 389.81K sh · $25.34M · Q3 2026
- Divisadero Street Capital Management, LP 700.94K sh · $19.98M · Q2 2026
- Portolan Capital Management, LLC 684.80K sh · $19.52M · Q2 2026
- Gagnon Advisors, LLC 286.89K sh · $18.65M · Q3 2026
- Palo Alto Investors LP 531.87K sh · $15.16M · Q2 2026
More on Kera Capital Partners, Inc.
FAQ
How long has Kera Capital Partners, Inc. held CDNA?
Kera Capital Partners, Inc. has disclosed CDNA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Kera Capital Partners, Inc.'s current position in CDNA?
As of Q3 2026, Kera Capital Partners, Inc. holds 91.11K shares of CDNA (CAREDX INC), valued at $6.30M, representing 0.52% of its reported portfolio and ranking #46.
Has Kera Capital Partners, Inc. been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Kera Capital Partners, Inc. held unchanged its position in CDNA. The position peaked in Q3 2026 at 91.11K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include ARK Invest, GAGNON SECURITIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.